Applied Nanodetectors’ modular nanosensor platform is designed for seamless integration into partner systems. The Exhale-Dx® intellectual property (IP) and asthma breath-test application are now owned by BreathPredict Ltd, an independent spin-out. Secure data transfer: Cloud platform conforms to regulatory requirements. Deep learning: Unique insights and personalised models. Low cost of ownership: Cost effective testing.
